Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank65
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P65
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 50.03% |
| Q2 2025 | -37.92% |
| Q1 2025 | 6.22% |
| Q4 2024 | 113.04% |
| Q3 2024 | 3.51% |
| Q2 2024 | -13.15% |
| Q1 2024 | -26.09% |
| Q4 2023 | -46.10% |
| Q3 2023 | 82.60% |
| Q2 2023 | 23.25% |
| Q1 2023 | 218.02% |
| Q4 2022 | 60.51% |
| Q3 2022 | -99.30% |
| Q2 2022 | -0.09% |
| Q1 2022 | 6719.08% |
| Q4 2021 | -98.54% |
| Q3 2021 | 37028.22% |
| Q2 2021 | 0.00% |